Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study

Documenti analoghi

• Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42
  di: Lauridsen, Camilla, et al.
  Pubblicazione: (2017)
• The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up
  di: Grøntvedt, Gøril Rolfseng, et al.
  Pubblicazione: (2020)
• Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study
  di: Berge, Guro, et al.
  Pubblicazione: (2016)
• Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease
  di: Almdahl, Ina S., et al.
  Pubblicazione: (2017)
• The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
  di: Twohig, Daniel, et al.
  Pubblicazione: (2018)